GLP-1 Injections in San Diego: A Deep Dive into Semaglutide & Tirzepatide Weight Loss Services
GLP-1 receptor agonists (glucagon-like peptide-1 agonists) are a newer class of medications that mimic a natural hormone involved in appetite regulation and blood sugar control. Semaglutide, a GLP-1 receptor agonist, works by activating GLP-1 receptors to slow gastric emptying, reduce appetite, and enhance insulin secretion, thereby promoting sustained weight loss in conjunction with diet and exercise. Tirzepatide goes further—it is a dual agonist that targets both GLP-1 and GIP receptors, potentially offering greater weight-loss outcomes through weight loss services in San Diego . Semaglutide and Tirzepatide: FDA Status and Effectiveness Semaglutide, marketed as Wegovy for weight loss (and Ozempic or Rybelsus for diabetes), has been FDA-approved for weight management and has shown results averaging 10–15% of body weight reduction within 6 to 12 months. Tirzepatide, sold as Zepbound (and Mounjaro for diabetes), received FDA approval for weight loss in November 2023. It has demon...